News
-
-
COMMUNIQUÉ DE PRESSE
AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024
Assemblée Générale Mixte de AB Science du 26 juin 2024 : toutes les résolutions ordinaires et extraordinaires adoptées sauf une. Actionnariat présent : 21.948.183 actions ordinaires et 38.495.615 droits de vote -
-
COMMUNIQUÉ DE PRESSE
iOmx Therapeutics Appoints Florian Schmid as New Chief Financial Officer
iOmx Therapeutics appoints Florian Schmid as new Chief Financial Officer, succeeding Marcus Irsfeld. Schmid brings 20+ years of financial leadership experience in biopharma. Company aims to advance immuno-oncology drug candidates -
COMMUNIQUÉ DE PRESSE
PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Group’s profit for 2023 following a successful business performance
PharmaSGP Holding SE's Annual General Meeting approves full profit distribution for 2023 after successful business performance. Peter Gerckens appointed as Chief Commercial Officer -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Nexans and SNCF Réseau revolutionize rail safety with an innovative superconducting fault current limiter
Nexans and SNCF Réseau introduce a groundbreaking superconducting fault current limiter to enhance railway safety and reliability in collaboration for a more efficient rail network and energy transition